J9322 Injection pemetrexed (bluepoint)
Also known as: pemetrexed Bluepoint, pemetrexed generic
Injection of pemetrexed from Bluepoint manufacturer. Multi-targeted antifolate for nonsquamous non-small cell lung cancer.
In Plain Language
lung cancer injection; mesothelioma treatment
Clinical Context
Bluepoint manufactured pemetrexed for lung cancer and mesothelioma therapy.
RVU Information
CPT J9322 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9322?
CPT J9322 (Injection pemetrexed (bluepoint)) is a J Codes (Drugs) code. Injection of pemetrexed from Bluepoint manufacturer. Multi-targeted antifolate for nonsquamous non-small cell lung cancer.
How is J9322 administered?
CPT J9322 is administered by a healthcare provider, typically via injection or infusion. Bluepoint manufactured pemetrexed for lung cancer and mesothelioma therapy. It is used by Oncology, Pulmonology, Surgery.
When is CPT J9322 used?
Bluepoint manufactured pemetrexed for lung cancer and mesothelioma therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.